CONMED Corporation
CNMD
$50.41
$0.591.18%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.42% | 4.14% | 5.18% | 4.61% | 3.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.42% | 4.14% | 5.18% | 4.61% | 3.94% |
| Cost of Revenue | 6.39% | 10.03% | 11.43% | 4.23% | 2.95% |
| Gross Profit | 1.11% | -0.43% | 0.29% | 4.91% | 4.72% |
| SG&A Expenses | 1.30% | 1.48% | 6.60% | 6.71% | 5.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.34% | 6.11% | 8.83% | 5.05% | 3.84% |
| Operating Income | -3.62% | -10.83% | -21.07% | 1.23% | 4.67% |
| Income Before Tax | -39.55% | -43.70% | -56.38% | -46.58% | 11.13% |
| Income Tax Expenses | -2.77% | 1.59% | -21.38% | -24.34% | 8.65% |
| Earnings from Continuing Operations | -48.73% | -53.81% | -64.47% | -51.37% | 11.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.73% | -53.81% | -64.47% | -51.37% | 11.77% |
| EBIT | -3.62% | -10.83% | -21.07% | 1.23% | 4.67% |
| EBITDA | -1.25% | -6.06% | -13.47% | 1.70% | 3.79% |
| EPS Basic | -48.06% | -53.80% | -64.59% | -51.56% | 11.32% |
| Normalized Basic EPS | 2.65% | -9.52% | -23.31% | 5.62% | 9.62% |
| EPS Diluted | -47.66% | -53.41% | -64.38% | -51.31% | 12.39% |
| Normalized Diluted EPS | 3.11% | -9.03% | -22.85% | 6.63% | 11.13% |
| Average Basic Shares Outstanding | -0.91% | -0.08% | 0.38% | 0.48% | 0.49% |
| Average Diluted Shares Outstanding | -1.32% | -0.61% | -0.28% | -0.47% | -0.88% |
| Dividend Per Share | -75.00% | -50.00% | -25.00% | 0.00% | 0.00% |
| Payout Ratio | -0.02% | 0.63% | 1.83% | 1.07% | -0.10% |